AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSL LIMITED

236.560

-2.790-1.17%

Volume:1.33M

Turnover:336.05M

Market Cap:114.55B

PE:26.72

High:239.000

Open:238.500

Low:236.200

Close:239.350

Loading ...

Overview Company News Filings

Stock Track | CSL LIMITED Soars 5.56% as Pharmaceutical Tariff Exemption Boosts Investor Confidence

What would Warren Buffett do with ASX shares in this market selloff? Probably this…

Trump 2.0: Macquarie's take on the winners and losers in Australian healthcare

Pharma Stocks Slide Further After Trump Reiterates Tariff Threats on Drugs -- Update

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

CSL May Need to Raise Prices to Offset Trump's Potential Pharma Tariffs -- Market Talk

Own CSL shares? You're getting a dividend paycheque today

BUZZ-Australia's CSL hits nearly 18-month low on tariff concerns

Stock Track | CSL Limited Plummets 6.58% as Trump Announces "Major" Tariff on Pharmaceuticals

Pharmaceuticals to be hit by ‘major’ Trump tariff, CSL slumps 5pc

The Australian Financial Review

These 3 ASX stocks look like strong buys after the market selloff

Trump’s hint of drug tariff a body blow for CSL

The West Australian

How this Trump appointee could pressure the CSL share price

BMRN vs. CSLLY: Which Stock Is the Better Value Option?

Bell Potter names more of the best ASX 200 stocks to buy in April

Here's a starter portfolio of ASX 200 shares to consider for growth, dividends, and value!

10 ASX shares to buy after the market selloff

Broker laments 'catastrophic negative surprise' that highlights the risks with these types of ASX shares

ASX 200 plunges as US tariffs fall-out continues

Is CSL the most defensive ASX stock on the market?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CSL.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":236.56,"timestamp":1745302320000,"preClose":239.35,"halted":0,"volume":1332774,"delay":0,"nameEN":"CSL LIMITED","floatShares":483950454,"shares":484212123,"eps":8.852640382691346,"marketStatus":"Closed","change":-2.79,"latestTime":"04-22 16:12:00 AEST","open":238.5,"high":239,"low":236.2,"amount":336048145,"amplitude":0.011698,"askPrice":237.5,"askSize":125,"bidPrice":236.51,"bidSize":98,"shortable":3,"etf":0,"ttmEps":8.852640382691346,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":239.35,"dividendRate":0.018145,"openAndCloseTimeList":[[1745280000000,1745301600000]],"volumeRatio":1.262872,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":483950454,"roa":"6.69%","roe":"14.35%","lyrEps":8.550925,"volumeRatio":1.262872,"shares":484212123,"dividePrice":4.299025,"high":239,"amplitude":0.011698,"preClose":239.35,"low":236.2,"week52Low":228.61,"pbRate":"3.95","psRate":"4.81","week52High":308.856,"institutionHeld":0,"latestPrice":236.56,"committee":-0.121076,"eps":8.852640382691346,"divideRate":0.018145,"volume":1332774,"delay":0,"ttmEps":8.852640382691346,"open":238.5,"prevYearClose":279.35,"prevWeekClose":239.35,"prevMonthClose":249.28,"prevQuarterClose":249.28,"fiveDayClose":233.08,"twentyDayClose":254,"sixtyDayClose":267.862},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1123560789","title":"Stock Track | CSL LIMITED Soars 5.56% as Pharmaceutical Tariff Exemption Boosts Investor Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=1123560789","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123560789?lang=en_us&edition=fundamental","pubTime":"2025-04-10 08:04","pubTimestamp":1744243470,"startTime":"0","endTime":"0","summary":"CSL LIMITED  saw its stock price surge by 5.56% in Thursday's pre-market trading session, as investors reacted positively to news that the company remains unaffected by the latest round of U.S. tariffs on pharmaceutical products. This comes as a relief to shareholders following a period of uncertainty in the healthcare sector due to global trade tensions.The rally in CSL's stock price appears to be a direct response to a recent report by Macquarie Group, which highlighted that CSL has escaped th","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | CSL LIMITED Soars 5.56% as Pharmaceutical Tariff Exemption Boosts Investor Confidence","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CSL.AU"],"gpt_icon":1},{"id":"2526342137","title":"What would Warren Buffett do with ASX shares in this market selloff? Probably this…","url":"https://stock-news.laohu8.com/highlight/detail?id=2526342137","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526342137?lang=en_us&edition=fundamental","pubTime":"2025-04-10 05:12","pubTimestamp":1744233165,"startTime":"0","endTime":"0","summary":"When markets fall and fear takes over, investors tend to ask the same question: What would Warren Buffett do?While we can't know for sure what the Oracle of Omaha would do with ASX shares during this market selloff, we can look to his decades of wisdom and actions for clues. And if history is any guide, there's a good chance he wouldn't be panicking — he would be preparing. What would Warren Buffett do with ASX shares?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/10/what-would-warren-buffett-do-with-asx-shares-in-this-market-selloff-probably-this/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7501","LU0154236417.USD","IE00B3S45H60.SGD","LU1201861249.SGD","LU0417517546.SGD","LU1366333091.USD","IE00BK4W5M84.HKD","LU0170899867.USD","IE00BJLML261.HKD","IE00BK4W5L77.USD","LU1363072403.SGD","IE00BWXC8680.SGD","LU0742534661.SGD","BK7511","BRK.B","BK4585","LU0234572021.USD","VAS.AU","LU0256863811.USD","LU1914381329.SGD","LU1074936037.SGD","LU0053666078.USD","WES.AU","BK4588","NDQ.AU","LU0980610538.SGD","LU1280957306.USD","LU0048573561.USD","LU0251131958.USD","BK4533","FDN","LU0234570918.USD","BK7508","LU0157215616.USD","CSL.AU","LU1571399168.USD","IE0034235303.USD","BK4550","LU0787776722.HKD","BK7153","IE00B775SV38.USD","BK4534","LU0149725797.USD","LU0971096721.USD","MQG.AU","LU0648001328.SGD","IE00B1XK9C88.USD","BK4176","LU0683600562.USD","MOAT.AU"],"gpt_icon":1},{"id":"2526990342","title":"Trump 2.0: Macquarie's take on the winners and losers in Australian healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2526990342","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526990342?lang=en_us&edition=fundamental","pubTime":"2025-04-10 05:12","pubTimestamp":1744233120,"startTime":"0","endTime":"0","summary":"] A key challenge for both RMD and FPH will be negotiations with US payors to increase pricing or widening co-payments. We note upside risk for both names if respiratory devices/apparatus are exempt from tariffs under the Nairobi Protocol implemented through the Harmonised Tariff Schedule.  That said, ResMed isn't completely immune. With part of its manufacturing based in Australia and Singapore, both now facing 10% tariffs, and rising input costs from tariffed raw materials, its earnings forecasts have been trimmed by 2% for FY 2026 and FY 2027. What about CSL and Cochlear?Biotech giant CSL Ltd  escaped the current round of tariffs, thanks to exemptions for pharmaceutical products. However, Macquarie flagged it as a name to watch. It said:  CSL is left unscathed by reciprocal tariffs as pharmaceuticals are exempted. However, potential sector tariffs remain a key risk for CSL in the near term.  As for Cochlear Ltd , it also sidestepped the tariff net, as hearing devices continue to enj","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/10/trump-2-0-macquaries-take-on-the-winners-and-losers-in-australian-healthcare/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7046","RMD.AU","COH.AU","BK7508","ANN.AU","CSL.AU","FPH.AU","XAO.AU","BK7067","XKO.AU","BK7007","BK7511","MQG.AU","XJO.AU","BK7126","BK7501"],"gpt_icon":0},{"id":"2526963233","title":"Pharma Stocks Slide Further After Trump Reiterates Tariff Threats on Drugs -- Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2526963233","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526963233?lang=en_us&edition=fundamental","pubTime":"2025-04-09 23:03","pubTimestamp":1744210980,"startTime":"0","endTime":"0","summary":"Pharmaceutical stocks sank lower Wednesday after President Trump doubled down on his promise to slap tariffs on a long-exempt industry, causing market turmoil globally.The Dow Jones U.S. Pharmaceuticals Index slipped 3.7% to 768.75 Wednesday morning, at one point hitting a 52-week low of 766.61. AbbVie shares fell 5.9% to $165.34, while Eli Lilly, Merck and Pfizer all declined about 3%.In European morning trade, the Stoxx Europe 600 Health Care index--which is heavily dominated by Europe's six largest pharma companies--dropped 3.1% Wednesday, also touching a year low earlier in the session.Switzerland's Roche and Novartis, the U.K.'s AstraZeneca, Denmark's Novo Nordisk and France's Sanofi were all down more than 5% in morning trade. Japan's Daiichi Sankyo and Takeda Pharmaceutical retreated 6% and 4.7%, respectively, while Australia's CSL shed 5%.The pharma sector had been spared last week from Trump's sweeping tariff plan, which kicked in Wednesday, and drug companies have been exempt","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","LU0158827948.USD","03165","LU1496350171.SGD","IE00BZ1G4Q59.USD","SG9999002224.SGD","NVO","ABBV","LU0070302665.USD","DSNKY","LU2237443382.USD","IE00B19Z3581.USD","IE00B3PB1722.GBP","BK7511","LU1983299246.USD","LU1066051811.HKD","LU2347655156.SGD","LU1003077747.HKD","LU0385154629.USD","LU0029864427.USD","IE00BJLML261.HKD","LU0943347566.SGD","BK7501","LU0708995401.HKD","LU0553294199.USD","LU0061475181.USD","LU1804176565.USD","SG9999001440.SGD","CSL.AU","LU2462157665.USD","LU0109391861.USD","SNY","LU2602419157.SGD","LU0208291251.USD","LLY","LU1720051108.HKD","LU1366192091.USD","SG9999015945.SGD","LU0265550359.USD","LU2552382132.HKD","RHHBY","AZN","LU0882574139.USD","LU1829250122.USD","TAK","NVS","LU2129689605.HKD","PFE","IE00BVYPNV92.GBP","LU1035775433.USD"],"gpt_icon":1},{"id":"2526133062","title":"Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2526133062","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526133062?lang=en_us&edition=fundamental","pubTime":"2025-04-09 17:24","pubTimestamp":1744190640,"startTime":"0","endTime":"0","summary":"Pharmaceutical stocks took a hit after U.S. President Trump said tariffs on pharma imports will be unveiled very shortly, signaling the industry could be next in line amid a trade war that is causing market turmoil globally.In European morning trade, the Stoxx Europe 600 Health Care index--which is heavily dominated by Europe's six largest pharma companies--was down 4.5%, against a 2.7% fall for the broader Stoxx Europe 600. The falls mirrored a selloff among pharma stocks in Asia.Switzerland's Roche and Novartis, the U.K.'s AstraZeneca and GSK and France's Sanofi were down 5% or more in morning trade. Japan's Daiichi Sankyo and Takeda Pharmaceutical closed 6% and 4.7% lower, while Australia's CSL shed 5%.The pharma sector was spared from Trump's sweeping tariff plan last week, which kicked in on Wednesday, but the U.S. president had previously pledged to impose tariff on pharma products and his remarks at a Tuesday dinner with House Republicans suggested levies could come soon.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","NVS","SG9999013999.USD","03165","LU1720051108.HKD","LU0965509283.SGD","LU1093756168.USD","BK4581","GSK","LU1732799900.SGD","PFE","SG9999002224.SGD","MRK","LU0289739699.SGD","LU2237443978.SGD","SG9999014575.USD","DSNKY","LU1934455277.USD","MDCO","IE00BDGV0183.EUR","LU2129689605.HKD","SG9999015986.USD","LU0965508806.USD","LU1988902786.USD","LU1551013342.USD","LLY","BK4559","LU1718418525.SGD","SGXZ99366536.SGD","LU0061475181.USD","LU0320765059.SGD","LU1989771016.USD","CSL.AU","RHHBY","LU0471298694.HKD","IE0009355771.USD","LU1868836591.USD","ABBV","SG9999017495.SGD","BK4007","LU2133065610.SGD","LU2264538146.SGD","LU1035773651.USD","TAK","GSK.UK","LU0203201768.USD","SG9999014567.USD","LU0965509101.SGD","LU1366192091.USD","LU0417517546.SGD"],"gpt_icon":1},{"id":"2526381051","title":"CSL May Need to Raise Prices to Offset Trump's Potential Pharma Tariffs -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2526381051","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526381051?lang=en_us&edition=fundamental","pubTime":"2025-04-09 15:01","pubTimestamp":1744182060,"startTime":"0","endTime":"0","summary":"0701 GMT - Australia-based biotech company CSL, which collects plasma in the U.S. and manufactures many plasma-based products at plants in Europe, would likely need to raise prices by between 4% to 5.1% to offset Trump's planned tariffs on pharmaceuticals, say Jefferies analysts. While it isn't clear exactly how the Trump pharmaceutical tariffs will work, the good news for CSL is that over time it may be able to move plasma product manufacturing from high tariff locations in Europe to lower tariff areas like Australia, say David Stanton and Vanessa Thomson. This will put it in a slightly better position than its major European competitors. But in general, \"plasma companies may see difficulties transferring complex, expensive operations at plants that can take years to build,\" they add. CSL shares ended 5% lower. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL","CSL.AU","BK7501","BK7067","BK7508","LU0728928796.USD","SG9999004303.SGD","LU1169590202.USD","SGXZ23171101.USD","BK7511","BK4086","LU1169589451.USD"],"gpt_icon":0},{"id":"2526406303","title":"Own CSL shares? You're getting a dividend paycheque today","url":"https://stock-news.laohu8.com/highlight/detail?id=2526406303","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526406303?lang=en_us&edition=fundamental","pubTime":"2025-04-09 11:29","pubTimestamp":1744169340,"startTime":"0","endTime":"0","summary":"The S&P/ASX 200 Index (ASX: XJO) is once again selling off this Wednesday, losing the momentum we saw yesterday, and dropping substantially so far this session. At the time of writing, the ASX 200 has","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/09/own-csl-shares-youre-getting-a-dividend-paycheque-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7511","LU1169590202.USD","LU0728928796.USD","BK7508","BK7501","XJO.AU","CSL.AU","BK4086","CSL","SG9999004303.SGD","SGXZ23171101.USD","BK7067","LU1169589451.USD"],"gpt_icon":0},{"id":"2526176872","title":"BUZZ-Australia's CSL hits nearly 18-month low on tariff concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2526176872","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526176872?lang=en_us&edition=fundamental","pubTime":"2025-04-09 10:08","pubTimestamp":1744164491,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's CSL hits nearly 18-month low on tariff concerns** Shares of CSL CSL.AX fall as much as 6.7% to A$229.2, their lowest level since Oct. 30, 2023. ** Shares trim some losses to last trade 4.6% lower. ** Biotech giant bears the brunt of U.S. plans to announce a \"major\" tariff on pharmaceutical imports** U.S. President Donald Trump said the tariff will incentivize drug companies to move their operations to the U.S.** Health stocks .AXHJ are down 2.3%, while the broader ASX 200 index .AXJO falls 1.2%** CSL has lost 12.7% YTD, including the day's move  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nL3N3QN05R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7511","CSL.AU","BK7067","BK7501"],"gpt_icon":0},{"id":"1175600331","title":"Stock Track | CSL Limited Plummets 6.58% as Trump Announces \"Major\" Tariff on Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=1175600331","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175600331?lang=en_us&edition=fundamental","pubTime":"2025-04-09 09:35","pubTimestamp":1744162516,"startTime":"0","endTime":"0","summary":"CSL Limited  saw its stock price plummet by 6.58% during intraday trading on Wednesday, following US President Donald Trump's announcement of a potential \"major\" tariff on pharmaceuticals. The dramatic drop in CSL's stock value reflects immediate investor concerns about the impact of this trade policy on the Australian pharmaceutical giant.President Trump, in a televised address to the National Republican Congressional Committee, stated his intention to impose tariffs on pharmaceutical imports, ","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | CSL Limited Plummets 6.58% as Trump Announces \"Major\" Tariff on Pharmaceuticals","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CSL.AU"],"gpt_icon":1},{"id":"2526287928","title":"Pharmaceuticals to be hit by ‘major’ Trump tariff, CSL slumps 5pc","url":"https://stock-news.laohu8.com/highlight/detail?id=2526287928","media":"The Australian Financial Review","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526287928?lang=en_us&edition=fundamental","pubTime":"2025-04-09 09:08","pubTimestamp":1744160880,"startTime":"0","endTime":"0","summary":"US President Donald Trump says he is preparing to announce a “major” tariff on pharmaceuticals in an expansion of his damaging trade war that would hit $1.6 billion in annual Australian exports.“We are going to tariff our pharmaceuticals and once we do that they’re going to come rushing back into our country because we’re the big market,” he said in a televised address to the National Republican Congressional Committee on Tuesday .Loading...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.afr.com/companies/healthcare-and-fitness/pharmaceuticals-to-be-hit-by-major-trump-tariff-csl-slumps-5pc-20250409-p5lqeo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"afr_stock","symbols":["SG9999004303.SGD","SGXZ23171101.USD","CSL.AU","BK7508","BK7501","BK4086","LU1169590202.USD","LU1169589451.USD","BK7511","CSL","LU0728928796.USD","BK7067"],"gpt_icon":0},{"id":"2526702078","title":"These 3 ASX stocks look like strong buys after the market selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2526702078","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526702078?lang=en_us&edition=fundamental","pubTime":"2025-04-09 07:30","pubTimestamp":1744155013,"startTime":"0","endTime":"0","summary":"The market has been rattled in recent weeks, and the numbers speak for themselves. The ASX 200 is down sharply from its highs, Wall Street has tumbled into correction territory, and investor sentiment","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/09/these-3-asx-stocks-look-like-strong-buys-after-the-market-selloff/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU1548497426.USD","LU2089284900.SGD","LU2133065610.SGD","LU0267386448.USD","LU1668664300.SGD","LU2089283258.USD","LU0912757837.SGD","LU0098860793.USD","LU1732800096.USD","LU1162221912.USD","BK7511","LU0971096721.USD","LU0106831901.USD","BK7508","BK7067","LU1732799900.SGD","BK4127","LU1363072403.SGD","LU1720051017.SGD","LU0314104364.USD","LU0320765646.SGD","IE00BKVL7J92.USD","LU0225283273.USD","BK4504","LU2023251221.USD","LU2111349929.HKD","LU1989772923.USD","LU0158827781.USD","MQG.AU","LU1989772840.SGD","BK4516","LU2271345857.HKD","LU2347655156.SGD","BK4534","LU0006306889.USD","IE00BZ1G4Q59.USD","LOV.AU","BK7501","LU0158827948.USD","LU0795875169.SGD","BK7128","LU1720051108.HKD","CSL.AU","LU1074936037.SGD","LU2357305700.SGD","BK4585","BK4581","BK4588","BK7046","LU0795875086.SGD"],"gpt_icon":0},{"id":"2526809287","title":"Trump’s hint of drug tariff a body blow for CSL","url":"https://stock-news.laohu8.com/highlight/detail?id=2526809287","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526809287?lang=en_us&edition=fundamental","pubTime":"2025-04-09 03:39","pubTimestamp":1744141176,"startTime":"0","endTime":"0","summary":"US President Donald Trump has signalled his administration will place a tariff on imported pharmaceuticals, a policy that is expected to directly hit Australia’s second-largest export to the US.","market":"hk","thumbnail":"https://images.thewest.com.au/publication/C-18313381/33cc698ff9c7a6fa116c82bac8e2b1efd8532479.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-18313381/33cc698ff9c7a6fa116c82bac8e2b1efd8532479.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/biotech/donald-trump-tariffs-csl-slumps-as-president-threatens-to-bring-pharmaceuticals-into-trade-war-c-18313381","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/biotech/donald-trump-tariffs-csl-slumps-as-president-threatens-to-bring-pharmaceuticals-into-trade-war-c-18313381","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["CSL.AU","BK7511","BK7508","XJO.AU","BK7067","LU1169589451.USD","SG9999004303.SGD","SGXZ23171101.USD","BK7501","XAO.AU","BK4086","XKO.AU","CSL","LU1169590202.USD","LU0728928796.USD"],"gpt_icon":0},{"id":"2525088010","title":"How this Trump appointee could pressure the CSL share price","url":"https://stock-news.laohu8.com/highlight/detail?id=2525088010","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525088010?lang=en_us&edition=fundamental","pubTime":"2025-04-08 12:08","pubTimestamp":1744085306,"startTime":"0","endTime":"0","summary":"The CSL Ltd (ASX: CSL) share price is enjoying a welcome rebound today. That's after shares got hammered amid the broader Trump tariff stock market sell-off over the past few trading days. Shares in t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/08/how-this-trump-appointee-could-pressure-the-csl-share-price/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["XJO.AU","CSL.AU","LU0728928796.USD","BK7508","BK7511","BK7067","BK7501","SG9999004303.SGD","CSL","LU1169590202.USD","SGXZ23171101.USD","BK4086","LU1169589451.USD"],"gpt_icon":1},{"id":"2525278070","title":"BMRN vs. CSLLY: Which Stock Is the Better Value Option?","url":"https://stock-news.laohu8.com/highlight/detail?id=2525278070","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525278070?lang=en_us&edition=fundamental","pubTime":"2025-04-07 23:40","pubTimestamp":1744040407,"startTime":"0","endTime":"0","summary":"Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of BioMarin Pharmaceutical  and CSL Limited Sponsored ADR . But which of these two stocks is more attractive to value investors?We'll need to take a closer look to find out.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.BioMarin Pharmaceutical has a Zacks Rank of #2 , while CSL Limited Sponsored ADR has a Zacks Rank of #3  right now. Investors should feel comfortable knowing that BMRN likely has seen a stronger improvement to its earnings outlook than CSLLY has recently. But this is just one factor that value investors are interested in.BioMarin Pharmaceutical Inc. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bmrn-vs-cslly-stock-better-154007797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BMRN","IE00B19Z3B42.SGD","IE0002270589.USD","IE00B19Z3581.USD","CSL.AU","BK4139","IE00B7SZLL34.SGD","CSLLY","BK4566"],"gpt_icon":0},{"id":"2525066549","title":"Bell Potter names more of the best ASX 200 stocks to buy in April","url":"https://stock-news.laohu8.com/highlight/detail?id=2525066549","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525066549?lang=en_us&edition=fundamental","pubTime":"2025-04-07 13:53","pubTimestamp":1744005233,"startTime":"0","endTime":"0","summary":"If you are looking for some new additions to your portfolio in April, then the ASX 200 stocks listed below could be worth a closer look. That's because they have been named onBell Potter'sAustralian E","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/07/bell-potter-names-more-of-the-best-asx-200-stocks-to-buy-in-april/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7067","BK7508","BK7511","CSL.AU","BK7016","BK7503","BK7501","JHX.AU","BK7044","WTC.AU"],"gpt_icon":0},{"id":"2525741468","title":"Here's a starter portfolio of ASX 200 shares to consider for growth, dividends, and value!","url":"https://stock-news.laohu8.com/highlight/detail?id=2525741468","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525741468?lang=en_us&edition=fundamental","pubTime":"2025-04-06 06:02","pubTimestamp":1743890520,"startTime":"0","endTime":"0","summary":"If you're just getting started on your investing journey and want to build a portfolio with long-term potential, the ASX 200 is a great place to begin. The key is to include a mix of quality companies","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/06/heres-a-starter-portfolio-of-asx-200-shares-to-consider-for-growth-dividends-and-value/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7503","BK7505","BK7041","BK7153","BK7007","BK7067","BK7511","BK7042","WES.AU","TLS.AU","SUL.AU","BK7040","BK7510","RMD.AU","BK7016","BK7128","BK7501","BK7508","XRO.AU","TWE.AU","COL.AU","GMG.AU","BK7099","BK7155","BK7097","MQG.AU","CSL.AU","BK7046","BK7082"],"gpt_icon":1},{"id":"2525575822","title":"10 ASX shares to buy after the market selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2525575822","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525575822?lang=en_us&edition=fundamental","pubTime":"2025-04-05 04:07","pubTimestamp":1743797220,"startTime":"0","endTime":"0","summary":"The recent share market selloff has rattled investor confidence — but for those thinking long term, it could be a gift in disguise. When share prices drop across the board, it often has less to do wit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/05/10-asx-shares-to-buy-after-the-market-selloff/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7040","LU0795875169.SGD","WTC.AU","LU1732800096.USD","BK4581","LU2750360641.GBP","MQG.AU","IE00B19Z3581.USD","LU2028103732.USD","LU0225283273.USD","LU2237443382.USD","BK7155","RMD.AU","LU0061475181.USD","LU0795875086.SGD","LOV.AU","LU1791807156.HKD","LU0971096721.USD","LU0251142724.SGD","TNE.AU","LU2237443549.SGD","BK7099","BK7016","LU2471134796.USD","LU1989772840.SGD","LU1989772923.USD","LU2237443978.SGD","BK7128","LU1074936037.SGD","LU2089283258.USD","LU2133065610.SGD","TLX.AU","WOW.AU","XRO.AU","BK7511","LU1162221912.USD","LU1868836757.USD","LU0314104364.USD","LU1868836591.USD","LU1868836914.USD","LU2237443465.HKD","LU2471134879.HKD","BK7007","BK4127","BK4552","GMG.AU","LU1732799900.SGD","BK4516","BK4588","CSL.AU"],"gpt_icon":0},{"id":"2525222758","title":"Broker laments 'catastrophic negative surprise' that highlights the risks with these types of ASX shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2525222758","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525222758?lang=en_us&edition=fundamental","pubTime":"2025-04-05 04:00","pubTimestamp":1743796800,"startTime":"0","endTime":"0","summary":"ASX share Opthea Limited (ASX: OPT)remains suspended from trading as the biotechcompany works to avoid insolvency.  Opthea last traded at 60 cents per share.   Last week, we learned that Opthea has de","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/05/broker-laments-catastrophic-negative-surprise-that-highlights-the-risks-with-these-types-of-asx-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7511","OPT","BK7508","BK7501","OPT.AU","XJO.AU","MSB.AU","CSL.AU","BK7067","BK4139"],"gpt_icon":0},{"id":"2524279082","title":"ASX 200 plunges as US tariffs fall-out continues","url":"https://stock-news.laohu8.com/highlight/detail?id=2524279082","media":"MotleyFool","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524279082?lang=en_us&edition=fundamental","pubTime":"2025-04-04 14:00","pubTimestamp":1743746431,"startTime":"0","endTime":"0","summary":"The S&P/ASX 200 Index  plummeted by 191.9 points or 2.44% on Friday to finish the week at 7,667.8 points.Uncertainty about how the newly announced reciprocal US tariffs will impact ASX 200 shares fuelled today's dive.Based on closing values, today's market rout has pushed the ASX 200 into an official market correction.A market correction is defined as a major index falling 10% from its most recent peak.The ASX 200 narrowly avoided a correction last month after it fell 9.43% from its record high on 14 February to a trough on 13 March.The fall saw several blue-chip sharestrading at multi-year lows, including Fortescue Ltd  and CSL Ltd .The ASX 200 began a rebound on 14 March, but this week's US tariffs news has brought that undone.The ASX 200 closed down 10.38% from its 14 February high today.Today, we heard from more companies about the potential impact of the tariffs on their operations.ASX 200 dives into official correction as more companies reveal US tariff impact. The ASX 200 biotec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/04/asx-200-plunges-as-us-tariffs-fall-out-continues/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["XJO.AU","BK7507","BK7067","BRG.AU","BK7051","BK7129","BK7508","ANN.AU","BK7119","CSL.AU","BK7126","FMG.AU","AOV.AU","BK7511","MSB.AU","BK7501"],"gpt_icon":0},{"id":"2524241549","title":"Is CSL the most defensive ASX stock on the market?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524241549","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524241549?lang=en_us&edition=fundamental","pubTime":"2025-04-04 06:59","pubTimestamp":1743721140,"startTime":"0","endTime":"0","summary":"Searching for a defensive stock to add to your portfolio?CSL Ltd  shares could be an option. What is a defensive stock?Defensive stocks are shares in  mature, dividend-paying companies. These companies also have a record of consistent profits regardless of the state of the broader economy.  Investors often associate them with industries like consumer staples, healthcare, utilities, and some food and beverage businesses – particularly fast-food chains. Demand for these products and services typically remains high even during an economic downturn. In the case of CSL, a global biotechnology company producing medicines and vaccines, it can be considered a defensive stock. This is because medicine and healthcare are essentials that people need to access regardless of economic conditions. Global uncertainty No stock is immune to the ebbs and flows of the global economy. After a rough 2025 so far for many portfolios, it's not outrageous to assume many investors will be looking towards defensi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/04/is-csl-the-most-defensive-asx-stock-on-the-market/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4086","CSL.AU","BK7067","BK7508","SGXZ23171101.USD","LU0728928796.USD","CSL","BK7511","LU1169590202.USD","LU1169589451.USD","SG9999004303.SGD","BK7501"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2025-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2025-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-09","payableDate":"2025-03-11","currency":"USD","dateTimestamp":1741525200000,"payDate":"2025-04-09"},{"date":"2025-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739228400000,"name":null,"time":"","dateTimestamp":1739192400000,"actualEps":null},{"date":"2024-09-09","symbol":"CSL.AU","amount":1.45,"announcedDate":"2024-08-13","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-10","defaultRemindTime":1725840000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-02","payableDate":"2024-09-10","currency":"USD","dateTimestamp":1725804000000,"payDate":"2024-10-02"},{"date":"2024-08-13","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723507200000,"name":null,"time":"","dateTimestamp":1723471200000,"actualEps":null},{"date":"2024-03-11","symbol":"CSL.AU","amount":1.19,"announcedDate":"2024-02-13","type":"dividend","market":"AU","newRecordDate":"2024-03-12","defaultRemindTime":1710111600000,"name":"CSL 公司","recordDate":"2024-04-03","payableDate":"2024-03-12","currency":"USD","dateTimestamp":1710075600000,"payDate":"2024-04-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}]}}